View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Daratumumab 16 / Pomalidomide 4 / Dexamethasone 40, Multiple Myeloma, Cycle 3-6
Protocol-ID: 1224 V2.1 (Mini), DRTM16/POMA4/DEXA(20/20/40), MM, C3-6Indication(s)
- Multiple Myeloma; ICD-10 C90.-, C90.0-
Links
- Daratumumab: Risiko der Reaktivierung von Hepatitis B [BfARM Risikoinf. Rote Hand etc.]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 24.04.2021